2019 Speakers
Kate Adcock, Director Of Research And Innovation, The Muscular Dystrophy U.K.
Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency
John Alter, Vice President Pricing And Market Access, Pfizer
Mauricio Alvarez Reyes, Market Access Director, Tesaro
Katerina Anokhina, Director, Medical Affairs, Uk And Ireland, Alexion Pharma UK
Diego Ardigo, Research And Development Rare Diseases Unit Head, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Philip Aubrey, Associate Director Market Access Biosimilars, Uk, Netherlands And Ireland, Biogen
Segolene Ayme, Founder Of Orphanet And Rare Disease Expert In Residence, ICM, Paris
Katja Berg, Vice President Of Operations And Payers Intelligence, Sanofi
Inge Bliestle, Commercial Director, Actelion
Axel Boehnke, Director Market Access (Global Responsibility), MorphoSys AG
Luc Boileau, Président-Directeur General, Inesss
David Boothe, Endocrinology Lead, HRA-Pharma
Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh
Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)
JUAN CASTANO, Lawyer health regulation enforceability, Management Science For Health
Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline
Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)
Don Creighton, Managing Director, Life Sciences Practice, Huron
Mike Crosher, Value And Access Director, Chugai Pharma UK
Omar Dabbous, Vice President Health Economics And Outcomes Research, AveXis Inc
Charles De Cidrac, Director Of Health Insurance, AXA
Carla Deakin, Associate Director, Office For Market Access, NICE
Stephen Deitch, Vice President, Charles River Associates
Mark Duman, Nw Service Champion, Diabetes U.K.
Rudy Dupree, Senior Project Manager, Zorginstituut
Jenny Ebert, National Account Director, Genzyme Sanofi Corp
David Elvira Martinez, Director Of The Catalan Health Service, CatSalut, Catalunya Health Service
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi
Diar Fattah, Associate Director Of Medicines Optimisation, N.H.S._Dartford Gravesham and Swanley C.C.G.
Matteo Ferrario, Value Strategy Manager, Roche
Martina Flammer, Senior Vice President, Head Of Customer Value, Boehringer Ingelheim Pharma GmbH & Co. KG
Alejandra (Sandra) Garitonandía, Business Development, Vistex
Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer
Ivan Glushkov, External Affairs Department Director, S.T.A.D.A.
Josie Godfrey, Independent, Duchenne
Adrian Griffin, Vice President, Hta And Reimbursement Policy, Johnson & Johnson
Tony Hebden, Vice President Of Health Economics And Outcomes Research, AbbVie
Birgit Holz, Global Head Of Contracting Innovation, Sanofi
Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb
Lucy Hoppe, Clinical Effectiveness Manager (Evidence Synthesis) In The Clinical Effectiveness Team, Bupa
Nigel Hughes, Scientific Director, Janssen
Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma
Dawn Ireland, President, CDH International
Daniel Jackson, Global Head Of Market Access, Solutions And Strategy, UCB
David Jakouloff, Global Head of Market Access, DMD, PTC Therapeutics
Saira Jan, Director Of Pharmacy Strategy And Clinical Integration, Blue Cross Blue Shield of New Jersey
Wendy Jory, Head of Global Pricing and Contracting Strategies, GlaxoSmithKline
Rosemary Jose, Associate Director of Strategic Market Access, Pharmerit International
Navin Joshi, Global Head Of Pricing, Classic And Established Products. Global Pharma, GlaxoSmithKline
Marcela Junqueira, Head Of Strategic Affairs And Health Economics, Janssen Pharmaceutical
Sachin Kamal-Bahl, Vice President And Head, Global Health And Value Innovation Center, Pfizer
Nicki Kang, Head Of Pricing Uk And Ireland, Merck Group
Daniel Knecht, Vice President, Clinical Strategy And Policy, Aetna
Alison Kneen, Practice Lead, DRG Abacus
Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis
Brett Kopelan, Executive Director, DebRa of America
Akshay Kumar, Senior Director, Huron Consulting Group
Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG
Giovanny Leon, Pricing And Market Access Director For Latin America And Canada, Novartis Ag
Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark
Qing Liu, Head of Biostatistics and Data Management, Amicus Therapeutics Inc
Catarina Lopes Pereira, Market Access Manager, Medicines for Europe
Francois Lucas, Senior Director, Huron Consulting Group
Elena Lungu, Manager, NPDUIS, PMPRB
Mark Macgregor, Interim Medical Director, Acute Services, Nhs Scotland
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Joerg Mahlich, Head Heor, Janssen Pharmaceutical K.K.
Farzana Malik, Vice President Market Access, Vicarius Pharma
Andrea Mantovani, Market Access Director, Abbott Diagnostics
Eva Marchese, Vice President, CRA International
Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita
Anne Marciniak, Head of Market Access, Europe, Aimmune
Alen Marijam`, Heor Senior Manager, Em, GlaxoSmithKline
Kevin Mayo, Head, Global Market Access - New Products, Shire Pharmaceuticals
Margaret Mcdonald, Senior Director, Global Market Access, Pfizer
Elizabeth Mckenna, Head Of Market Access Uk And Ireland, Vertex Pharmaceuticals
Paul Mcloughlin, VP of Market Access & Phase IV Solutions, Covance
Soniya Mokashi, Global Senior Medical Affairs Physician, Norgine
Patrick Mollon, Former Director Gheore, Shire
Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health
Aurelie Moser, Head of Access LABs, Roche
Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Bundesministerium fur Gesundheit
Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer
Sue Naeyaert, Global Head Government Affairs And Policy Biosimilars, Fresenius Kabi
Alexander Natz, Secretary General, EUCOPE
Paul Newton, Director Strategic Pricing, UCB
Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical
Waldemar Ockert, Director, RWI Business Market Analytics, Astellas
Irina Odnoletkova, VP Health Technology Assessment, Apogenix
Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma
Vitaly Omelyanovskiy, General Director, Center Of Healthcare Quality Assessment And Control, Ministry of Health
Nneka Onwudiwe, Founder and Chief Executive Officer, Pharmacoeconomics Consultants of America
Mario Ouwens, Statistical Science Director, Astra Zeneca
Elizabeth Owen, Head Of Translational Research Development, The Muscular Dystrophy U.K.
Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Geert Pelsmaeker, General Manager, Leaphy
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer Ingelheim Biopharmaceuticals Gmbh
Dan Pettitt, Global Head Of Immunology Market Access, Johnson & Johnson
Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Lara Pippo, Head Of Market Access, C.S.L. Behring Spa
Adam Plich, Former Vice President, Head Of Pricing And Market Access Europe, Teva
Robert Popovian, Vice President Of Government Relations, Pfizer
Diann Potestio, VP Market Access, Ascendis Pharma A/S
Rafaat Rahmani, President, Lifescience Dynamics Ltd
Marco Rauland, Vice President, Map GmAndE And Training Academy, Global Market Access And Pricing, Biopharma| Global Operations, Merck Group
S Ravetkar, Executive Director, Serum Institute of India Ltd
Ajan Reginald, Chief Executive Officer, Celixir
Andreia Ribeiro, Engagement Manager, Lifescience Dynamics Ltd
Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency
Katja Rudell, Honorary Research Fellow, Queen Mary University of London
Igor Rudychev, Senior Director, Business Insights, AstraZeneca
Peter Rutherford, Global Medical Lead Of Orphan Renal Diseases, Vifor Pharma Group
Emily Saadi, Senior Undergraduate, Health Care Policy & Management, Georgetown University
Ryan Saadi, VP, Global Market Access, CSL Behring
Steve Sandor, Vice President, Market Access and Trade, Paratek Pharmaceuticals , Inc.
Stefan Scherer, Vice President Head Of Early Development Strategy, McKesson Specialty Health The U.S. Oncology Network
Gundula Schneidewind, Managing Director, Takeda Belgium
Michael Schroter, Partner, Viopas Partners
Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands
Ayman Semaan, Head of Market Access, Algorithm
Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen
Maurício Silva De Lima, Vice President, Us Medical Affairs Head, Spectrum Medical Unit, Genentech
Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England
Anindita Sinha, Director, Global Market Access, Pfizer
Matt Slabbert, Head Of Market Access, Advocacy And Policy, Anz, Bayer Pharmaceuticals
Erik Smets, Vice President And Head Of Patient Experience And Value, UCB Biopharma
Jan Span, Member Of The Cross-Committee Task Force On Registries And Senior Clinical Assessor, Medicines Evaluation Board The Netherlands
Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm
Richard Stephens, Chair Of Consumer Liaison Group, National Cancer Research Institute (NCRI)
Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center
Simon Swift, Managing Director, Methods Analytics
Bertrand Tardivel, General Manager, Frehel GmbH
Renske Ten Ham, Phd Candidate, Utrecht University
Gwilym Thompson, Director Worldwide Heor, BMS
Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD
Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany
Keiko Tone, VP Global Market Access, Shionogi Inc
Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health
Dr Josep Torrent-Farnell, Medicines Department, Catalan Health Service
Isabel Torres, Vice President Market Access, Public Affairs And Patient Advocacy For Europe And Canada, Takeda
Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence
Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences Belgium Bvba
Goedele Van Haasteren, Hta Specialist, Bundesamt fur Gesundheit
Christina Vandoros, Director, Macroeconomics & Health Policy - EMEA, Janssen
Kart Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia
Bart Vermeulen, Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health, Belgian Federal Government
Jaume Vidal, Policy Advisor, Eu Projects, Health Action International
Reg Waldeck, Market Access Strategy Leader, Bayer Corp
David Watson, Director Pricing And Reimbursement, Association of the British Pharmaceutical Industry
Lindsay Weaver, Executive Director, Children Living With Inherited Metabolic Diseases
David Williams, Chief Medical Officer, Visformatics
Fabrizio Zucca, Director Patient Access Dach, Sobi
Organiser
